Welcome

Thank you for your interest in this Delphi study on the European List of Essential Medicines for Medical Education. This study is in the name of the Education Working Group of the European Association of Clinical Pharmacology and Therapeutics (EACPT).

On this page you can find the following information:

  • Summary of the study
  • The two information letters
  • The full protocol
  • Contact information

Summary

Junior doctors are responsible for a substantial number of prescribing errors, and final-year medical students lack sufficient prescribing knowledge and skills just before they graduate. Various national and international projects have been initiated to reform the teaching of clinical pharmacology and therapeutics (CP&T) during undergraduate medical training. However, there is as yet no list of commonly prescribed and available medicines that European doctors should be able to independently prescribe safely and effectively without direct supervision. Such a list could form the basis for a European Prescribing Exam and would harmonise European CP&T education.

Aim: The aim of this study is to reach consensus on a list of widely prescribed medicines, available in most European countries, that European junior doctors should be able to independently prescribe safely and effectively without direct supervision: the European List of Essential Medicines for Medical Education.

Planning:

Phase Aim Participants Round(s) Starting date Date of reminder 1 Date of reminder 2 End date
1 Constructing drug list with all widely available medicines Coordinators 1 September 13, 2021 September 20, 2021 None September 27, 2021
2

 

 

Constructing the European List of Essential Medicines for Medical Education Coordinators + selected experts

 

1 October 18, 2021 October 25, 2021 November 1, 2021 November 8, 2021
2 November 29, 2021 December 6, 2021 December 13, 2021 December 20, 2021

Information letter

We have two information letters. Please read the letter that belongs to you:

Coordinator: Click here

Expert participant: Click here

Study protocol

For our study protocol, see our publication in the BMJ Open.

Contact information

For further information about the survey or the research, please contact Erik Donker (English or Dutch language) by telephone at: +31 20 444 8020 or via email (English or Dutch language): e.donker@amsterdamumc.nl.